Cargando…

Combined First Month Body Weight Loss and Development of Tolerance as Predictors of 6-Month Efficacy of Mazindol in Mild and Moderate Obese Subjects

The weight loss response to anti-obesity drugs is highly variable and poorly understood, which does not allow us to know, in advance, in which subjects the drug will be effective and in which it will not. The objective of this study was to explore the body weight reduction in kilograms in the first...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huerta-Cruz, Juan Carlos, Rocha-González, Héctor Isaac, Kammar-García, Ashuin, Canizales-Quinteros, Samuel, Barranco-Garduño, Lina Marcela, Reyes-García, Juan Gerardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181115/ https://www.ncbi.nlm.nih.gov/pubmed/35683598 http://dx.doi.org/10.3390/jcm11113211

Ejemplares similares

Weight Loss at First Month and Development of Tolerance as Possible Predictors of 30 mg Phentermine Efficacy at 6 Months
por: Rocha-González, Héctor Isaac, et al.
Publicado: (2021)

Metformin improves the weight reduction effect of mazindol in prediabetic obese Mexican subjects
por: Arguelles-Tello, Federico Alberto, et al.
Publicado: (2022)

Three- and six-month efficacy and safety of phentermine in a Mexican obese population
por: Márquez-Cruz, Maribel, et al.
Publicado: (2021)

Estimation of vaccination coverage and associated factors in older Mexican adults
por: García-Hernández, Héctor, et al.
Publicado: (2023)

All-cause mortality among patients treated with repurposed antivirals and antibiotics for COVID-19 in Mexico City: A real-world observational study
por: Mancilla-Galindo, Javier, et al.
Publicado: (2021)

Pilot Phase II study of mazindol in children with attention deficit/hyperactivity disorder
por: Konofal, Eric, et al.
Publicado: (2014)

Cognitive Impairment and Neuropsychiatry Manifestation Following Mild and Moderate Traumatic Brain Injury at 3 Months and 6 Months
por: Othman, Aizzat, et al.
Publicado: (2022)

Dietary Patterns and Their Association with Metabolic Syndrome and Their Components in Middle-Class Adults from Damascus, Syria: A Cross-Sectional Study
por: Atasi, Malda, et al.
Publicado: (2022)

Repeated administration of mazindol reduces spontaneous pain-related behaviors without modifying bone density and microarchitecture in a mouse model of complete Freund’s adjuvant-induced knee arthritis
por: Robledo-González, LE, et al.
Publicado: (2017)

Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients
por: Lucchetta, Rosa Camila, et al.
Publicado: (2017)

SOFA Score Plus Impedance Ratio Predicts Mortality in Critically Ill Patients Admitted to the Emergency Department: Retrospective Observational Study
por: Kammar-García, Ashuin, et al.
Publicado: (2022)

ERRATUM: Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients
Publicado: (2018)

Sequelae in adults at 12 months after mild‐to‐moderate coronavirus disease 2019 (COVID‐19)
por: Boscolo‐Rizzo, Paolo, et al.
Publicado: (2021)

Single-step Transepithelial photorefractive keratectomy in the treatment of mild, moderate, and high myopia: six month results
por: Xi, Lei, et al.
Publicado: (2018)

A cohort study on anxiety and perceived recovery 3 and 12 months after mild to moderate stroke
por: Nelsone, Linda, et al.
Publicado: (2023)

Antineuropathic effect of 7-hydroxy-3,4-dihydrocadalin in streptozotocin-induced diabetic rodents
por: Rocha-González, Héctor Isaac, et al.
Publicado: (2014)

Burden and severity of mpox in Mexico 6 months into the outbreak
por: Núñez, Isaac, et al.
Publicado: (2023)

A 12-month prospective exploratory study of muscle and fat characteristics in individuals with mild-to-moderate hip osteoarthritis
por: Loureiro, Aderson, et al.
Publicado: (2019)

Lipid based nutrient supplements (LNS) for treatment of children (6 months to 59 months) with moderate acute malnutrition (MAM): A systematic review
por: Gera, Tarun, et al.
Publicado: (2017)

Association of loneliness and social isolation with all-cause mortality among older Mexican adults in the Mexican health and aging study: a retrospective observational study
por: Kammar-García, Ashuin, et al.
Publicado: (2023)

Four-month operational heat acclimatization positively affects the level of heat tolerance 6 months later
por: Malgoyre, Alexandra, et al.
Publicado: (2020)

Inhaled granulocyte-macrophage colony stimulating factor for mild-to-moderate autoimmune pulmonary alveolar proteinosis - a six month phase II randomized study with 24 months of follow-up
por: Tian, Xinlun, et al.
Publicado: (2020)

Effects of a Dental Gel Over 6 Months on Periodontal Health in Subjects with Stage II and III (Mild and Moderate) Periodontitis
por: Lin, Kairong, et al.
Publicado: (2019)

GPR55 and GPR119 Receptors Contribute to the Processing of Neuropathic Pain in Rats
por: Zúñiga-Romero, Ángel, et al.
Publicado: (2022)

Hemodynamic and respiratory support in pulmonary embolism: a narrative review
por: Pérez-Nieto, Orlando Rubén, et al.
Publicado: (2023)

Use of coconut water (Cocus nucifera L) for the development of a symbiotic functional drink
por: Segura-Badilla, Orietta, et al.
Publicado: (2020)

Commentary to: Hyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality
por: Guerrero-Gutiérrez, Manuel Alberto, et al.
Publicado: (2022)

Safety and Tolerability of Six Months of Isoniazid Plus Pyridoxine or Three Months of Rifampicin for Tuberculosis among Subjects with Diabetes Mellitus: A Randomized Trial
por: Tamez-Torres, Karla M., et al.
Publicado: (2023)

Differential Gene Expression of Subcutaneous Adipose Tissue among Lean, Obese, and after RYGB (Different Timepoints): Systematic Review and Analysis
por: Cruz-García, Elena Marisol, et al.
Publicado: (2022)

Cognitive and Affective Changes in Mild to Moderate Alzheimer’s Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A 6-Month Observational Study
por: Spalletta, Gianfranco, et al.
Publicado: (2014)

Good rate of clinical response to cholinesterase inhibitors in mild and moderate Alzheimer's disease after three months of treatment: An open-label study
por: de Miranda, Luis Felipe José Ravic, et al.
Publicado: (2013)

Fluticasone furoate/vilanterol 92/22 µg once a day: a 12-month study on outcomes in mild to moderate asthma
por: Dal Negro, Roberto W., et al.
Publicado: (2018)

SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19
por: Glück, Vivian, et al.
Publicado: (2021)

Plasmatic Levels and Response to Variable Doses of Monthly Aripiprazole and Three-Month Paliperidone in Patients with Severe Schizophrenia. Treatment Adherence, Effectiveness, Tolerability, and Safety
por: Fernández-Miranda, Juan J, et al.
Publicado: (2023)

Potential use of banana peel (Musa cavendish) as ingredient for pasta and bakery products
por: Segura-Badilla, Orietta, et al.
Publicado: (2022)

Effectiveness and Safety of Secukinumab in Latin American Patients with Moderate to Severe Plaque Psoriasis: PURE Registry 12-Month Data
por: Papp, Kim A., et al.
Publicado: (2022)

UX15-month-by-month
Publicado: (2003)

UX15-month-by-month
Publicado: (2004)

A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD)
por: Wigal, Tim L., et al.
Publicado: (2018)

Response to inhaled granulocyte‐macrophage colony‐stimulating factor in patient with mild‐to‐moderate autoimmune pulmonary alveolar proteinosis—24 months of follow‐up
por: Oterino‐Moreira, Iván, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8bha8uifr5vl2fijbhshn676nc